ACH
MTCR

ArrowMark Colorado Holdings’s Metacrine, Inc. Common Stock MTCR Stock Holding History

ArrowMark Colorado Holdings’s Portfolio MTCR Stock Details MTCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-281,467
Closed -$965K – 378
2021
Q3 		$965K Sell
281,467
-764,674
-73% -$2.38M 0.01% 314
2021
Q2 		$3.98M Sell
1,046,141
-13,701
-1% -$56.7K 0.03% 251
2021
Q1 		$6.57M Buy
1,059,842
+31,547
+3% +$279K 0.05% 226
2020
Q4 		$8.08M Sell
1,028,295
-9,154
-0.9% -$84K 0.06% 199
2020
Q3 		$10.6M Buy
+1,037,449
New +$10.6M 0.1% 140

Other funds holding MTCR

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

ArrowMark Colorado Holdings's MTCR Position: Q4 2021 in Review

ArrowMark Colorado Holdings sold out of Metacrine, Inc. Common Stock (MTCR) in Q4 2021, closing a stake of 281,467 shares — an estimated $965K sold.

ArrowMark Colorado Holdings first reported a position in MTCR in Q3 2020 and held it in 5 quarters. The position peaked at $10.6M in Q3 2020. 31 funds tracked by Wall St. Rank hold MTCR as of Q4 2021.

  • ArrowMark Colorado Holdings reported no remaining Metacrine, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 281,467 Metacrine, Inc. Common Stock shares in Q4 2021, an estimated $965K.
  • ArrowMark Colorado Holdings first reported a position in Metacrine, Inc. Common Stock in Q3 2020 and held it in 5 quarters.
  • ArrowMark Colorado Holdings's Metacrine, Inc. Common Stock position peaked at $10.6M in Q3 2020.
  • 31 funds tracked by Wall St. Rank held Metacrine, Inc. Common Stock as of Q4 2021.

Based on ArrowMark Colorado Holdings's 13F filing for Q4 2021, filed 14 Feb 2022.